The Evidence Speaks (March 2021)
To mark Kidney Health Month, this edition includes the safety of dialysis during COVID-19, corticosteroid use post-kidney transplant, and prescription patterns in dialysis patients
Read MoreMarch 1, 2021
To mark Kidney Health Month, this edition includes the safety of dialysis during COVID-19, corticosteroid use post-kidney transplant, and prescription patterns in dialysis patients
Read More
A clinical trial for a new COVID-19 treatment developed by Vancouver biotech company AbCellera is about to launch in B.C., thanks to the expertise of CHÉOS staff
Read More
In recognition of Rare Disease Day, CHÉOS Scientist Dr. Larry Lynd shares an insight into his work investigating the diagnosis, treatment, and management of rare diseases
Read More
As we enter into another exciting year of improving health outcomes for B.C. and beyond, we’re reflecting on some of the CHÉOS research from the past year
Read More
CHÉOS Scientist Dr. Joseph Puyat helped design the evaluation of the toolkit, in collaboration with colleagues at St Paul’s and VCH
Read More
This edition includes deprescribing algorithms for hemodialysis patients, PROMs in fall prevention, and frailty and health after heart valve surgery
Read More